SCHEMBL20732829

SCHEMBL20732829

Brc1ccnc2ccc(-c3ccc(N4CCOCC4)cc3)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 8/20 0.60
MAPK10 P53779 1/20 0.55
ACVR1B P36896 2/20 0.51
TGFBR1 P36897 2/20 0.51
BMPR1B O00238 1/20 0.51
PDGFRB P09619 1/20 0.51
KIT P10721 1/20 0.51
PDGFRA P16234 1/20 0.51
BMPR1A P36894 1/20 0.51
ACVRL1 P37023 1/20 0.51
ACVR1 Q04771 1/20 0.51
MAPK1 P28482 3/20 0.48
LMNA P02545 2/20 0.48
CYP3A4 P08684 2/20 0.48
CLK4 Q9HAZ1 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.48
HIF1A Q16665 1/20 0.48
MAPT P10636 2/20 0.47
AHR P35869 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28505160 0.84 MAPKAPK2 (0.60) MAPKAPK2MAPK10ACVR1BTGFBR1BMPR1B
SCHEMBL31464797 0.84 MAPKAPK2 (0.66) MAPKAPK2MAPK10ACVR1BTGFBR1BMPR1B
SCHEMBL28502016 0.82 MAPKAPK2 (0.57) MAPKAPK2MAPK10ACVR1BTGFBR1BMPR1B
SCHEMBL20733053 0.81 MAPKAPK2 (0.56) MAPKAPK2MAPK10ACVR1BTGFBR1BMPR1B
SCHEMBL20732831 0.80 MAPKAPK2 (0.55) MAPKAPK2MAPK10ACVR1BTGFBR1BMPR1B
SCHEMBL20732830 0.78 MAPKAPK2 (0.53) MAPKAPK2MAPK10ACVR1BTGFBR1BMPR1B
SCHEMBL20732922 0.78 MAPKAPK2 (0.53) MAPKAPK2MAPK10ACVR1BTGFBR1BMPR1B
SCHEMBL28275901 0.75 PIK3CA (0.59) ACVR1LMNACLK4MAPTCDK8
SCHEMBL23999520 0.73 MAPKAPK2 (0.54) MAPKAPK2MAPK10ACVR1BTGFBR1BMPR1B
SCHEMBL30210341 0.73 LGMN (0.53) MAPKAPK2MAPK10ACVR1BTGFBR1BMPR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3666770-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS Joint Stock Company "Biocad" (RU) 2020-06-17 EP disclosed
WO-2019031990-A1 NOVEL HETEROCYCLIC COMPOUNDS AS CDK8/19 INHIBITORS ЗАКРЫТОЕ АКЦИОНЕРНОЕ ОБЩЕСТВО "БИОКАД" 2019-02-14 WO disclosed